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ABSTRACT
Objective: The purpose of this retrospective study was to compare the clinical outcome and charac-
teristics ofpelvic inflammatory disease (PID) complicated by tubo-ovarian abscess (TOA) with PID
without TOA.
Methods: Chart reviews were performed for all PID admissions to the University ofMedicine and
Dentistry ofNew Jersey-University Hospital, Newark, NJ, from January 1, 1992, to December 31,
1993.
Results: The incidence in this study ofTOA based on sonographic evidence of a complex adnexal
mass was 18%. The major differences between the patients with and withoutTOAs were 1) history
of hospitalization for PID: 68% (13/19) vs. 29% (25/85); 2) increased erythrocyte sedimentation
rate: 82 vs. 41 mm/h; 3) increased WBC count on admission: 16,200 vs. 14,700/ml; 4) failure to
respond to initial antibiotic therapy; and 5) longer hospital stay: 7.8 vs. 4.4 days, respectively.
Surgical intervention was required in 3 patients: 2 patientswho hadTOAs and I patientwho did not
have aTOA by clinical examination or by ultrasound.
Conclusions: Despite longer hospital stays and blood tests suggesting more severe disease pro-
cesses, PID complicated by TOA is usually responsive to intravenous (IV) antibiotic therapy
without the need for surgical intervention. (C) 1995 Wiley-Liss, Inc.
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elvic inflammatory disease (PID) is a syndrome
that may include endometritis, parametritis, sal-
pingitis, oophoritis, pelvic peritonitis, and tubo-
ovarian abscess (TOA). About million women
per year are treated for acute PID, resulting in an
estimated annual cost of more than $4 billion.
TOAs have been reported to occur in as many as
34% of hospitalized patients with PID.
2-4 PID
complicated by a TOA carries a poorer prognosis
than uncomplicated PID. The presence of a TOA
is more likely to require surgical intervention.
The present study reports the epidemiology and
clinical outcomes of hospitalized patients with PID.
MATERIALS AND METHODS
Chart reviews were done for all PID admissions to
the University of Medicine and Dentistry of New
Jersey-University Hospital, Newark, NJ, from
January 1, 1992, to December 31, 1993. All pa-
tients met the published criteria for the clinical
diagnosis of acute PID. s These criteria include
lower abdominal tenderness, cervical motion ten-
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TABLE I. Demographic and historical characteristics of patients hospitalized with PID
PID without TOA PID with TOA
(N 85) (N 19)
Mean age (years) 25 29 NS
Gravity 3 4 NS
Parity 2 2 NS
Prior admission for PID 25 (29%) 13 (68%) 0.0029
History of drug abuse 20 (24%) 3 (16%) NS
History of IV drug use 10 (12%) 2 (I I%) NS
History of alcohol use 20 (24%) (5%) NS
ap value calculated by Student’s t-test. NS not significant.
derness, and bilateral adnexal tenderness, plus or
more of the following: temperature >38C, WBC
>10,000/ml, purulent material on culdocentesis,
evidence of pelvic abscess by ultrasonography or
pelvic examination, evidence of gonococcal cervici-
tis (by Gram’s stain showing gram-negative intra-
cellular diplococci), or mucopurulent cervicitis.
A total of 113 PID patients were admitted dur-
ing the study period. Nine patients were excluded
from the study: 4 patients with pyelonephritis,
patient with pneumonia, patient with small-bowel
obstruction, patient with active pulmonary tuber-
culosis, patient with an uncertain diagnosis of
PID vs. acute appendicitis, and patient with a
missing chart.
There were 85 cases of uncomplicated PID and
19 cases of PID complicated by pelvic masses or
suspected TOAs. All patients with evidence of a
pelvic mass by physical examination or an inade-
quate pelvic examination underwent sonography.
The patients who had sonographic evidence of pel-
vic masses and those who met the clinical criteria
for the diagnosis of PID were categorized as PID
complicated by TOA. Human immunodeficiency
virus (HIV) testing was offered to all patients, with
25% (26/104) refusing. Endocervical cultures for
Neisseria gonorrhoeae and Chlamydia trachomatis
(by Microtrak, Syva Company, San Jose, CA, or
Chlamydiazyme, Abbott Laboratories, North Chi-
cago, IL) were performed on all patients. Urine
cultures were tested in all patients. A blood culture
was obtained if the patient’s temperature was
>38C.
All except 7 patients were treated with intrave-
nous (IV) cefoxitin/doxycycline or gentamicin/
clindamycin, as recommended by the CDC.
6 Ampi-
cillin was added in a patient with suspected or
sonographically proven evidence of a TOA. Imi-
penem-cilastatin (Primaxin) was used in patients
who "failed" ampicillin/gentamicin/clindamycin.
Treatment failure was defined as a lack of clinical
improvement in symptomatology and persistently
elevated WBC counts after 48-72 h of IV antibi-
otic therapy. Seven patients were treated with
ampicillin/sulbactam and doxycycline based on a
prior research protocol comparing the efficacy of
ampicillin/sulbactam and doxycycline to cefoxitin
and doxycycline or gentamicin and clindamycin.
As statistical analysis was performed using Fish-
er’s exact test for discrete variables and Student’s
t-test for continuous variables. P < 0.05 was con-
sidered statistically significant.
RESULTS
The prevalence of TOAs among patients hospital-
ized for PID at the University Hospital was 18%
(19/104). The presenting clinical findings for pa-
tients with uncomplicated PID (no inflammatory
adnexal mass) and those with TOAs were similar.
Table shows that there were no statistically signif-
icant differences between these 2 groups in age,
gravity, parity, history of drug abuse, or history of
alcohol abuse. However, the patients with TOAs
had a higher rate of prior hospitalization for PID
(68% vs. 29%, respectively; P 0.003).
Table 2 summarizes the laboratory findings on
admission. Significantly elevatedWBC counts were
noted on admission (16,200/ml vs. 14,700/ml, re-
spectively; P 0.010). The erythrocyte sedimen-
tation rates were also significantly elevated in pa-
tients with TOAs (82 vs. 41 mm/h, respectively;
P 0.0002). The hematocrits were similar in both
groups. The results of all endocervical cultures and
admitting temperatures were not different between
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TABLE 2. Admitting laboratory findings in patients with TOA vs. patients without TOA
PID without TOA PID with TOA
(N 85) (N 19)
WBC (mean/ml) 14,753
Temperature (C) 38.39
Hematocrit (%) 36.8
ESR (mm/h) 41
Endocervical culture
GC 13-1actamase positive 6 (7%)
GC 13-1actamase negative 36 (42%)
Chlarnydia trachomatis 17 (20%)
Group B streptococcus II (13%)
Escherichia coli 5 (6%)
Staphylococcus aureus 0
16,285
38.44
37.2
82
i(s%)
4(21%)
2 (,o%)
2(1%)
o
(s%)
0.01
NS
NS
0.0002
NS
NS
NS
NS
NS
NS
ap value calculated by Student’s t-test and Fisher’s exact test. NS not significant.
bESR erythrocyte sedimentation rate.
cGC N. gonorrhoeae.
TABLE 3. Results of HIV testing
PID without TOA
(N 8S)
PID with TOA
(N 19)
HI test accepted 64 (75%) 14 (74%)
HI positive 9 (14%) (7%)
HIV negative 55 (86%) 13 (93%)
NS
NS
NS
aP value calculated by Fisher’s exact test. NS not significant.
TABLE 4. Treatment failures and duration of hospital stay
PID without TOA
(N 85)
PID with TOA
(N 19) pa
Failed initial IV antibiotic therapy
Surgical intervention needed
Mean hospital stay (days)
3 (3.5%) 8 (42%) <0.0001
(I.2%) 2 (10%) 0.085
4.4 7.8 <0.0001
P value calculated by Student’s t-test and Fisher’s exact test.
the 2 groups. Among the patients with TOAs, 26%
(5/19) had N. gonorrhoeae (21% being 13-1actamase
negative and 5% being [3-1actamase positive) and
10% (2/19) had C. trachomatis. Among the patients
without TOAs, N. gonorrhoeae was isolated in 49%
(42% being 13-1actamase negative and 7% being
[3-1actamase positive) and 20% (17/85) had C. tra-
chomatis.
Of all study patients, 75% (7 8/104) accepted
I-IIV testing. As noted in Table 3, both groups of
patients had similar acceptance rates for I-IIV test-
ing. Of the 75% who had HIV testing, 12.8%
(10/7 8) were found to be HIV positive by enzyme-
linked immunosorbent assay (ELISA) and West-
ern blot, 14% (9/64) with uncomplicated PID and
7% (1/14) with TOAs [P not significant (NS)].
Table 4 is a summary of the treatment failures
and durations of hospital stay. Failed initial IV
antibiotic therapy was defined as a lack of clinical
improvement in symptomatology and persistently
elevatedWBC counts after 48-72 h ofIV cefoxitin/
doxycycline or gentamicin/clindamycin therapy. In
the group with TOAs, 42% (8/19) failed initial IV
antibiotic therapy in comparison with 4% (3/85) of
the group without TOAs (P < 0.0001). However,
most patients in both groups improved clinically
when different antibiotics such as ampicillin/
gentamicin/clindamycin or imipenem-cilastatin
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were used. The need for surgical intervention was
not significantly different between the 2 groups.
Three (2.9%) patients required surgical interven-
tions. One patient with no sonographic evidence of
TOA who failed IV antibiotic therapy was HIV
negative. She received IV gentamicin/clindamycin
for 48 h with no clinical improvement. The antibi-
otic therapy was then switched to imipenem-
cilastatin/doxycycline for another 48 h with no clin-
ical improvement. She underwent an exploratory
laparotomy and bilateral salpingectomy. Microab-
scesses were noted during the surgery, and the his-
tologic findings were consistent with acute suppu-
rative salpingitis. Two patients with TOAs required
surgical intervention. Both patients were placed on
ampicillin/gentamicin/clindamycin for approxi-
mately 48 h, followed by imipenem-cilastatin for
>48 h without improvement. Each of these pa-
tients underwent a unilateral adnexectomy.
All PID patients were advised to have follow-up
visits in the clinic after discharge. Ultrasonography
was obtained for every PID patient complicated by
a pelvic mass. A surgical resection was advised to
each patient with a persistent mass.
The mean hospital stay was longer for patients
with TOAs compared with patients without TOAs
(7.8 vs. 4.4 days, respectively; P < 0.0001).
DISCUSSION
A TOA is a well-recognized complication of PID.
Its etiology is polymicrobial. Three major groups
of microorganisms play etiologic roles in PID: N.
gonorrhoeae, C. trachomatis, and a wide variety of
anaerobic and aerobic bacteria. Although our study
showed no differences in bacteriology between com-
plicated and uncomplicated PID, anaerobic cul-
tures were not done in the majority of the patients.
The exact mechanism of TOA formation is diffi-
cult to establish.
7 Studies have shown that patho-
gens can ascend to the fallopian tube, attach them-
selves to mucosal epithelial cells, penetrate the
epithelial cells through phagocytosis, and cause de-
struction of the epithelial cells, resulting in puru-
lent exudate production. 8’9 The abscess may re-
main localized, involving only the tube and ovary,
or it may involve the uterus, bowel, bladder, or
opposite adnexa.
PID complicated by a TOA carries a signifi-
cantly higher morbidity and mortality than uncom-
plicated PID. In this study, only 68% (13/19) of
the patients with TOAs had histories ofPID, which
may be explained by the possibility of a previous
subclinical infection or by the presence of certain
pathogens that are more likely to cause abscess for-
mation.
3
There are many etiologies for a pelvic mass,
including follicular cyst, ovarian neoplasm, uterine
leiomyoma, hydrosalpinx, and TOA. A large num-
ber of retrospective studies have evaluated the accu-
racy of ultrasonography in the diagnosis of a pelvic
abscess. Landers and Sweet reported on a series
of 31 patients with surgically confirmed TOAs
who were evaluated with ultrasonography. Of the
31 surgically confirmed cases, 29 were reported as
complex adnexal masses or cystic-type masses with
multiple internal echoes by ultrasound. Only 2 pa-
tients had surgically proven TOAs in our group of
patients with presumed PID complicated by TOAs.
All of the other patients met the clinical criteria for
PID as well as pelvic masses consistent with TOAs
by ultrasonography.
HIV testing is strongly advisable in all patients
with PID. The incidence ofHIV seropositivity was
12.8% (10/78) among our patients hospitalized
with PID. This rate is comparable to the 13.6%
rate reported by investigators ofKings County Hos-
pital Center in Brooklyn, NY.
l However, inves-
tigators from San Francisco General Hospital re-
ported the HIV seropositivity rate to be only 6.7%
in patients with PID.
2 I-Ioegsberg et al.
12 re-
ported no statistically significant difference in sur-
gical intervention between HIV-seropositive and
HIV-seronegative patients. Our study supports this
finding. Furthermore, the incidence of TOA was
similar in these 2 groups of patients: 14% (9/64) of
the patients with uncomplicated PID and 7% (1/
14) with complicated PID were HIV positive
(P NS). However, since only 10 HIV-positive
patients were identified in the study and the power
of the study was limited, a difference in clinical
outcome may be found when more patients are
studied.
There is general agreement that a rupturedTOA
requires surgical intervention. In the past, prompt
surgical intervention with complete removal of the
uterus and adnexa was performed.
3-s Neverthe-
less, because of intraoperative complications such as
bowel injury,
4 loss of reproductive and ovarian
functions, a total abdominal hysterectomy and bi-
lateral salpingo-oophorectomy may not be an opti-
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real treatment. In our series of 104 patients, most
patients with TOAs improved with IV antibiotics.
No statistically significant difference was noted in
surgical intervention between these 2 groups.
Therefore, we believe that conservative medical
therapy plays an important role in the treatment of
PID complicated by TOA. In a patient with a
unilateral TOA unresponsive to IV antibiotics, a
unilateral adnexectomy is the procedure of choice if
she desires future fertility.
In conclusion, the major differences between the
PID patients with and without TOAs were 1) his-
tory of hospitalization for PID, 2) increased eryth-
rocyte sedimentation rate, 3) increased WBC count
on admission, 4) failure to respond to initial antibi-
otic therapy, and 5) longer hospital stay. No differ-
ences were noted in age, parity, drug or alcohol
use, results of endocervical cultures, HIV seropos-
itivity rate, or need for surgical intervention.
These results suggest that a patient with PID
complicated by a TOA suspected by ultrasound is
usually responsive to IV antibiotics without the need
for surgical intervention.
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